Immunomedics
News/ News/ Oncology/ Top stories
Gilead pays $21bn for Immunomedics ahead of breast cancer trial readout
Richard Staines
AstraZeneca, Daiichi Sankyo, Gilead, Immunomedics, M&A, triple negative breast cancer
0 Comment
X
Gilead pays $21bn for Immunomedics ahead of breast cancer trial readout
https://pharmaphorum.com/news/gilead-pays-21bn-for-immunomedics-ahead-of-breast-cancer-trial-readout/